All News
Filter News
Found 808,690 articles
-
Drug Delivery Across Blood Brain Barrier Market Segmentation and Analysis Report, 2031
6/27/2022
Wilmington, Delaware, United States: The global drug delivery across blood brain barrier market is projected to expand at a favorable rate from 2021 to 2031.
-
Veterinary Artificial Insemination Market: Rise in Demand for High Quality Milk Products is Expected to Drive the Global Market
6/27/2022
Wilmington, Delaware, United States: Artificial insemination is a technique, in which semen with live sperm is collected and introduced into female reproductive tract at proper time with help of equipment.
-
Veterinary Care Market to Experience Significant Growth by 2031
6/27/2022
Wilmington, Delaware, United States: The government bodies of many countries across the globe are taking initiatives to ensure the availability of optimal inventory at fields for the treatment of different farm animals.
-
Endoscope Reprocessing Market Analysis and Opportunity Assessment 2021 - 2031
6/27/2022
Wilmington, Delaware, United States: Endoscopy-related infections are a worldwide concern for healthcare industry, with emergent risks propelling the need for robust processing protocols.
-
Femtech Market to Make Great Impact in Near Future by 2031
6/27/2022
Wilmington, Delaware, United States: Female-centric health technology and wellness products have emerged as vastly lucrative market.
-
Hemostats Market Size Expected to Grow at 6.35% of Highest CAGR by 2028 with Industry Analysis, Global Share, Future Market Trends and Application Forecast
6/27/2022
DBMR released a report titled "Hemostats Market" which delivers detailed overview of the Hemostats market in terms of market segmentation by type, route of administration, end-user, and by region.
-
Stool Softener Market Size to Reach USD 1.53 Billion in 2027 | Emergen Research
6/27/2022
The global stool softener market size was USD 1.53 Billion in 2021 and is expected to register a revenue CAGR of 7.15% during the forecast period, according to latest analysis by Emergen Research.
-
Laboratory Information Management Systems (LIMS) Market Growing at CAGR of 9.3% with Industry Share, Growth, Competitive Landscape And Regional Outlook by 2029
6/27/2022
This Laboratory Information Management Systems (LIMS) market report underlines the specific study of the Healthcare industry which explains what the market definition, classifications, applications, engagements, and global industry trends are.
-
Single Use Bioprocessing Market Size to Reach USD 17.10 Billion in 2030 | Emergen Research
6/27/2022
The single-use bioprocessing market size was USD 17.10 Billion in 2021 and is expected to register a revenue CAGR of 17.2% during the forecast period, according to the latest analysis by Emergen Research.
-
Healthcare Analytics Market to Reach Impressive CAGR Growth of 24.58% by 2029 with Size, Share, Growth, Demand, Revenue and Key Players Analysis
6/27/2022
DBMR has added a new report titled Healthcare Analytics Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis.
-
Pompe Disease Market Size to Reach USD 1386.09 Million in 2030 | Emergen Research
6/27/2022
The global Pompe Disease market size reached USD 1,386.09 Million in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period, according to a latest analysis by Emergen Research.
-
In Vitro Fertilization Services Market Size to Reach USD 13.61Billion in 2030 | Emergen Research
6/27/2022
The global In Vitro Fertilization (IVF) services market size is expected to reach USD 31.77 Billion in 2030 and register a steady revenue CAGR of 9.84% over the forecast period, according to latest analysis by Emergen Research.
-
Home Healthcare Market Size to Reach USD 179.56 Billion in 2027 | Emergen Research
6/27/2022
The global home healthcare market size was USD 179.56 Billion in 2020 and is expected to register a revenue CAGR of 8.4%, during the forecast period, according to latest analysis by Emergen Research.
-
CAR-T Cell Therapy Market Size to Reach USD 1.29 Million in 2030 | Emergen Research
6/27/2022
The global CAR T-cells therapy market size reached USD 1.29 Billion in 2021 and is expected to register a revenue CAGR of 24.9% during the forecast period, according to latest analysis by Emergen Research.
-
Artificial Intelligence in Cancer Diagnosis & Therapy Market Size to Reach USD 367.90 Million in 2030 | Emergen Research
6/27/2022
According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Moreover, as per the same source, about 70% of all cancer deaths occur in low- and middle-income countries.
-
Italfarmaco Group Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Patients with Duchenne Muscular Dystrophy
6/26/2022
Italfarmaco Group announced positive topline data from its completed Phase 3 EPIDYS trial with Givinostat, the company’s proprietary histone deacetylase inhibitor, in boys with Duchenne Muscular Dystrophy.
-
Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application
6/26/2022
On June 15, 2022, Dragon Boat announced that its IND application of the innovative anti-CLDN 18.2/CD47 bi-specific antibody injection was officially accepted by National Medical Products Administration under the acceptance number CXSL2200267.
-
Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D
6/25/2022
Sanyou Biopharmaceuticals, a biological high-tech enterprise focusing on R&D and services of innovative antibody drugs, and Dragon Sail Pharmaceutical, a CDMO and CMO enterprise dedicated to providing world-leading high-end biological drug manufacture services, announced a long-term strategic partnership taking effective.
-
Antios Therapeutics' ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study; ATI-1428 and ATI-1645 Exhibit Potent Antiviral Activity in a Nonclinical Study
6/25/2022
Antios Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for hepatitis B virus, announced new data from the Phase 2a clinical trial of ATI-2173, its lead investigational proprietary drug candidate and the only Active Site Polymerase Inhibitor Nucleotide in clinical development for HBV.
-
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
6/25/2022
Pfizer Inc. and BioNTech SE announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent, a combination of the Pfizer-BioNTech COVID-19 Vaccine and a vaccine candidate targeting the spike protein of the Omicron BA.1 variant of concern.